​

Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

OverviewForecastRevenueFinancialsChart

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 69.29% institutional investors, 1.25% insiders, and 29.46% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.34% of RPTX shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.65% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRepare Therapeutics69.29%1.25%29.46%
SectorHealthcare Stocks 79.82%9.81%10.37%
IndustryBiotech Stocks 63.50%9.87%26.63%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il10.33M24.34%$13.54M
Blue owl capital lp3.44M8.11%$4.51M
Orbimed advisors3.32M7.83%$4.35M
Versant venture management2.65M6.23%$3.47M
Ark investment management2.00M4.71%$2.62M
Redmile group1.92M4.51%$2.51M
Mpm asset management1.68M3.97%$2.21M
Aquilo capital management1.29M3.05%$1.69M
Bioimpact capital1.23M2.90%$1.61M
Acadian asset management472.10K1.11%$613.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management2.65M4.00%$3.47M
Aquilo capital management1.29M2.56%$1.69M
Mpm asset management1.68M1.77%$2.21M
Blue owl capital lp3.44M1.04%$4.51M
Bvf inc/il10.33M0.46%$13.54M
Bioimpact capital1.23M0.23%$1.61M
Redmile group1.92M0.17%$2.51M
Orbimed advisors3.32M0.09%$4.35M
Ark investment management2.00M0.02%$2.62M
Affinity asset advisors100.00K0.02%$131.00K

Top Buyers

HolderShares% AssetsChange
Aquilo capital management1.29M2.56%304.35K
Jpmorgan chase85.80K-85.80K
Blackrock141.80K-80.54K
Blue owl capital lp3.44M1.04%71.16K
Millennium management170.96K0.00%67.64K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---904.26K
Artal group---700.00K
Mpm asset management1.68M1.77%-558.93K
Ark investment management2.00M0.02%-509.74K
Bioimpact capital1.23M0.23%-408.69K

New Positions

HolderShares% AssetsChangeValue
Ubs group15.30K-15.30K$20.05K
Group one trading6.59K-6.59K$8.63M
Jones financial companies lllp100.00-100.00$131.00
Bnp paribas arbitrage, snc1.00-1.00$1.00

Sold Out

HolderChange
Royal bank of canada-275.00
Qube research-299.00
National bank of canada /fi/-435.00
Lazard asset management-594.00
Entrypoint capital-1.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202551-5.56%29,511,633-3.64%691.33%20-16-15.79%
Dec 31, 202424-57.89%6,082,941-81.22%140.25%9-52.63%7-61.11%
Sep 30, 202457-10.94%32,384,039-4.15%761.19%19-26.92%18-
Jun 30, 202464-13.51%33,787,658-4.85%801.13%2623.81%18-30.77%
Mar 31, 2024742.78%35,510,875-2.75%841.12%21-34.38%2618.18%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution ETF1.13M2.65%-1.65K
ARK Genomic Revolution1.10M2.59%-872.23K
Nikko Gbl All Biological Genome Eq MF297.64K0.70%-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH160.00K0.38%-
Northern Small Cap Core I92.06K0.22%92.06K
Vanguard Health Care ETF52.29K0.12%-567.00
Biotech Growth Ord49.26K0.12%-
Range Cancer Therapeutics ETF47.41K0.11%-
NT Quality SCC US Fund - L47.20K0.11%47.20K
NT Quality Small Cap Core47.20K0.11%47.20K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 12, 2025Koehler Maria EVP, CHIEF MEDICAL OFFICERSell$4.10K
Mar 12, 2025Zinda Michael EVP, CHIEF SCIENTIFIC OFFICERSell$6.40K
Mar 12, 2025Forte Steve EVP, CHIEF FINANCIAL OFFICERSell$7.85K
Mar 12, 2025Segal Lloyd Mitchell PRESIDENT AND CEOSell$24.14K
Mar 28, 2024Segal Lloyd Mitchell PRESIDENT AND CEOSell$12.24K

Insider Transactions Trends

DateBuySell
2025 Q1-4
2024 Q2-4
2024 Q1-16
2023 Q49-
2023 Q2-3

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 69.29%, followed by 1.25% insiders and 29.46% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 63.50%, which Repare Therapeutics exceeds.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.34%), Blue owl capital lp (3.44M shares, 8.11%), and Orbimed advisors (3.32M shares, 7.83%). Together, they hold 40.28% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.00% of its assets in 2.65M Repare Therapeutics shares, valued at 3.47M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Repare Therapeutics shares, with 2.65% of its total shares outstanding invested in 1.13M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools